$4.28
0.0350.83%
Last update: Jul 2, 11:12 AM
Aquestive Therapeutics Inc Earnings Estimates
AQSTNASDAQ
Aquestive Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AQST
Aquestive Therapeutics (AQST) is scheduled to report Q2 earnings on August 10, 2026. Analysts estimate EPS of $-0.12 and quarterly revenue of $11.70M.
In the most recent quarter (Q1), Aquestive Therapeutics reported EPS of $-0.07, beating estimates of $-0.13 by 0.46%. Revenue came in at $14.45M, exceeding the estimate of $10.88M by 0.33%.
Over the last 4 quarters, Aquestive Therapeutics has averaged an EPS surprise of 0.28% and a revenue surprise of 0.12%.
Earnings Date
Aug 10
EPS Estimate
$-0.120
Quarterly Revenue Estimate
$11.70M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$50.27M
Aquestive Therapeutics Earnings History
Analyze the earnings history of Aquestive Therapeutics using advanced sorting and filters.
Loading calendar...
Aquestive Therapeutics (AQST) Earnings Per Share
The chart below shows Aquestive Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Aquestive Therapeutics (AQST) Revenue
The chart below shows Aquestive Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?
Aquestive Therapeutics (AQST) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on May 13, 2026 for Q1.
What were the latest earnings per share (EPS) for Aquestive Therapeutics (NASDAQ:AQST)?
The Actual EPS was $-0.07, which beat the estimate of $-0.13.
What were Aquestive Therapeutics’s (NASDAQ:AQST) revenues?
The Actual Revenue was $14.45M, which beat the estimate of $10.88M.
